Total Number of Communication Reports: 2
Monthly communication reports in the last 6 months: 0
On December 8th, 2005, GlaxoSmithKline purchased all the issued and outstanding shares of ID Biomedical Corporation. The Corporation has nonetheless survived the closing of the above noted transaction and now carries on business as IB Biomedical Corporation cob as GlaxoSmithKline Biologicals North America. The Corporation is an integrated biotechnology company dedicated to the development of innovative vaccine products. It operates in research, development, manufacturing, sales and marketing from its facilities in Canada and in the United States.
John Picken, President
Address:
525 Cartier Blvd. West
Laval, QC H7V 3S8
Canada
Telephone number:
450-978-6301
Fax number:
450-978-7956
ID BIOMEDICAL CORPORATION does not have any subsidiaries that could have a direct interest in the outcome of the undertaking